UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A platform for brain-wide imaging and reconstruction of individual neurons

eLife, 2016-01, Vol.5, p.e10566-e10566

2016

Volltextzugriff (PDF)

Vibrissa-Based Object Localization in Head-Fixed Mice

The Journal of neuroscience, 2010-02, Vol.30 (5), p.1947-1967

2010

Volltextzugriff (PDF)

Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies

BMC cancer, 2021-01, Vol.21 (1), p.7-10, Article 7

2021

Volltextzugriff (PDF)

Automated tracking of whiskers in videos of head fixed rodents

PLoS computational biology, 2012-07, Vol.8 (7), p.e1002591-e1002591

2012

Volltextzugriff (PDF)

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

British journal of cancer, 2012-01, Vol.106 (3), p.508-516

2012

Volltextzugriff (PDF)

The mechanical variables underlying object localization along the axis of the whisker

The Journal of neuroscience, 2013-04, Vol.33 (16), p.6726-6741

2013

Volltextzugriff (PDF)

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial

Annals of oncology, 2011-04, Vol.22 (4), p.857-862

2011

Volltextzugriff (PDF)

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Clinical and translational radiation oncology, 2018-08, Vol.12, p.16-20

2018

Volltextzugriff (PDF)

Circulating melanoma cells and survival in metastatic melanoma

International journal of oncology, 2011-03, Vol.38 (3), p.755-760

2011

Volltextzugriff (PDF)

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies

Investigational new drugs, 2015-06, Vol.33 (3), p.679-690

2015

Volltextzugriff (PDF)

Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: A short communication

Journal of pharmaceutical and biomedical analysis, 2013-10, Vol.84, p.184-188

2013

Volltextzugriff (PDF)

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

Human reproduction (Oxford), 2006-02, Vol.21 (2), p.545-553

2006

Volltextzugriff (PDF)

A Prototypical Process for Creating Evidentiary Standards for Biomarkers and Diagnostics

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.368-371

2008

Volltextzugriff (PDF)

Systems Pharmacology Modeling of Prostate‐Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down‐Regulator

CPT: pharmacometrics and systems pharmacology, 2016-05, Vol.5 (5), p.258-263

2016

Volltextzugriff (PDF)

Electrostatic readout of DNA microarrays with charged microspheres

Nature biotechnology, 2008-07, Vol.26 (7), p.825-830

2008

Volltextzugriff (PDF)

Many-Particle Tracking with Nanometer Resolution in Three Dimensions by Reflection Interference Contrast Microscopy

Langmuir, 2005-07, Vol.21 (14), p.6430-6435

2005

Volltextzugriff (PDF)

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours

The HUGO journal, 2010-12, Vol.4 (1-4), p.11-21

2010

Volltextzugriff (PDF)

Src inhibitors in early breast cancer: a methodology, feasibility and variability study

Breast cancer research and treatment, 2009-03, Vol.114 (2), p.211-221

2009

Volltextzugriff (PDF)

Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2‐Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

Journal of bone and mineral research, 2006-08, Vol.21 (8), p.1215-1223

2006

Volltextzugriff (PDF)

Medical graduates evaluate the effectiveness of their education

Medical education, 1994-09, Vol.28 (5), p.418-431

Clack, G. B.

1994

Volltextzugriff (PDF)

The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol

Journal of obstetrics and gynaecology, 2010-08, Vol.30 (6), p.596-604

2010

Volltextzugriff (PDF)

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose phase I trial

Journal of bone and mineral research, 2010-03, Vol.25 (3), p.463-471

2010

Volltextzugriff (PDF)

Like-charge interactions between colloidal particles are asymmetric with respect to sign

Soft matter, 2009-05, Vol.5 (9), p.1931-1936

2009

Volltextzugriff (PDF)

230MO First in human, modular study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced solid malignancies

Annals of oncology, 2021-09, Vol.32, p.S458-S458

2021

Volltextzugriff (PDF)

265P Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)

Annals of oncology, 2021-09, Vol.32, p.S477-S478

2021

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(148)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A platform for brain-wide imaging and reconstruction of individual neurons

Vibrissa-Based Object Localization in Head-Fixed Mice

Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies

Automated tracking of whiskers in videos of head fixed rodents

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

The mechanical variables underlying object localization along the axis of the whisker

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Circulating melanoma cells and survival in metastatic melanoma

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies

Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: A short communication

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

A Prototypical Process for Creating Evidentiary Standards for Biomarkers and Diagnostics

Systems Pharmacology Modeling of Prostate‐Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down‐Regulator

Electrostatic readout of DNA microarrays with charged microspheres

Many-Particle Tracking with Nanometer Resolution in Three Dimensions by Reflection Interference Contrast Microscopy

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours

Src inhibitors in early breast cancer: a methodology, feasibility and variability study

Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2‐Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

Medical graduates evaluate the effectiveness of their education

The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose phase I trial

Like-charge interactions between colloidal particles are asymmetric with respect to sign

230MO First in human, modular study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced solid malignancies

265P Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)

Suchergebnisse filtern